Please try another search
For the fiscal year ended 31 December 2021, Osprey Medical Inc revenues increased 17% to $2M. Net loss decreased 25% to $10M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Lower net loss reflects Sales and marketing decrease of 11% to $5.1M (expense), Research and Development decrease of 9% to $2M (expense), General and administrative decrease of 1% to $3.4M (expense).
Period Ending: | Dec 31, 2021 | Jun 30, 2021 | Dec 31, 2020 | Jun 30, 2020 |
---|---|---|---|---|
Total Revenue | 0.89 | 1.07 | 0.86 | 0.81 |
Gross Profit | 0.35 | 0.35 | 0.28 | 0.17 |
Operating Income | -5.95 | -6.5 | -5.94 | -7.45 |
Net Income | -4.86 | -5.18 | -5.94 | -7.44 |
Period Ending: | Dec 31, 2021 | Jun 30, 2021 | Dec 31, 2020 | Jun 30, 2020 |
---|---|---|---|---|
Total Assets | 7.06 | 12.94 | 7.89 | 11.96 |
Total Liabilities | 1.87 | 3.2 | 3.49 | 3.1 |
Total Equity | 5.19 | 9.74 | 4.39 | 8.85 |
Period Ending: | Dec 31, 2021 | Jun 30, 2021 | Dec 31, 2020 | Jun 30, 2020 |
---|---|---|---|---|
Period Length: | 12 Months | 6 Months | 12 Months | 6 Months |
Cash From Operating Activities | -11.66 | -6.03 | -12.71 | -7.57 |
Cash From Investing Activities | -0.08 | -0.05 | -0.26 | -0.24 |
Cash From Financing Activities | 11.35 | 11.35 | 10.48 | 9.31 |
Net Change in Cash | -0.4 | 5.26 | -2.49 | 1.5 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review